Saliva swabs may reveal hidden virus threat in kidney transplants

NCT ID NCT07256470

Not yet recruiting Knowledge-focused Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tracks BK virus in saliva, urine, and blood of 100 kidney transplant recipients over one year. The goal is to see if the virus spreads through saliva and how it affects the new kidney. Participants collect their own saliva samples at home, plus give urine and blood at clinic visits. The study does not test any treatment, only observes the virus.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Salivary self-collection
What this could lead to: If successful, this could help doctors understand how BK virus spreads and improve monitoring to protect transplanted kidneys.
What could go wrong: This is an observational study, not a treatment trial. It will not directly change patient care, and results may not lead to new guidelines.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BK VIRUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

BK-virus nephropathy kidney disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BK VIRUS DNAEMIA KIDNEY TRANSPLANTATION NEPHROPATHY SALIVARY REPLICATION

Contacts and locations

Locations

CHU Amiens Picardie

Amiens, Picardie, 80054, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.